Jason Cole
Advanced Heart Failure and Transplant Cardiology Omaha, NE Medical Doctor
NPI 1407273667 CMS profile 1282449
8200 Dodge St, Omaha, NE 68114
General payments
$155
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Jason Cole of Omaha, NE is reported in the CMS Open Payments database as having received $155 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 4th percentile of Advanced Heart Failure and Transplant Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $155 | 2 |
Beside peers
- Jason Cole
- Advanced Heart Failure and Transplant Cardiology median
- Middle half of Advanced Heart Failure and Transplant Cardiology
- National median
In program year 2025, general payments to Jason Cole were reported at $155. Among 967 Advanced Heart Failure and Transplant Cardiology profiles paid that year, the median was $1,024 and the middle half received between $289 and $6,890.
Show as a table
| Year | Jason Cole | Advanced Heart Failure and Transplant Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $863 | $224–$4,562 | $163 |
| 2020 | $0 | $452 | $122–$3,992 | $114 |
| 2021 | $0 | $550 | $159–$3,571 | $132 |
| 2022 | $0 | $729 | $221–$4,357 | $149 |
| 2023 | $0 | $1,002 | $309–$5,827 | $160 |
| 2024 | $0 | $931 | $273–$5,204 | $164 |
| 2025 | $155 | $1,024 | $289–$6,890 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Advanced Heart Failure and Transplant Cardiology in Nebraska
Scott Lundgren
Advanced Heart Failure and Transplant Cardiology · Omaha, NE
Douglas Stoller
Advanced Heart Failure and Transplant Cardiology · Omaha, NE
Arif Albulushi
Advanced Heart Failure and Transplant Cardiology · Bellevue, NE
Selma Mohammed
Advanced Heart Failure and Transplant Cardiology · Omaha, NE
Brian Lowes
Advanced Heart Failure and Transplant Cardiology · Omaha, NE
Mathue Baker
Advanced Heart Failure and Transplant Cardiology · Lincoln, NE
Related records
Advanced Heart Failure and Transplant Cardiology in Nebraska
Practitioners in the same specialty and state, ranked by reported value.
All Advanced Heart Failure and Transplant Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Nebraska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.